Next Article in Journal
Ultrasonographic and Radiographic Evaluation of Osteoarthritic Changes in the Temporomandibular Joint
Next Article in Special Issue
Immune Checkpoint Inhibitor-Related Sjögren’s Syndrome: An Ocular Immune-Related Adverse Event
Previous Article in Journal / Special Issue
Radiological and Surgery Considerations and Alternatives in Total Temporomandibular Joint Replacement in Gorlin-Goltz Syndrome
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Interesting Images

18F-FDG PET/CT Findings in Glandular Tularemia

by
Freja Gustafsson
1,*,
Karl Keigo Rasmussen
2,
Kristina Thorsteinsson
3,
Anne-Mette Lebech
1,4 and
Lasse Fjordside
1
1
Department of Infectious Diseases, Copenhagen University Hospital—Rigshospitalet, Blegdamsvej 9, DK-2100 Copenhagen, Denmark
2
Department of Nuclear Medicine, Copenhagen University Hospital—Bispebjerg, Bispebjerg Bakke 23, DK-2400 Copenhagen, Denmark
3
Department of Pulmonary and Infectious Diseases, Copenhagen University Hospital—Bispebjerg, Bispebjerg Bakke 23, DK-2400 Copenhagen, Denmark
4
Department of Clinical Medicine, University of Copenhagen, Blegdamsvej 3B, DK-2200 Copenhagen, Denmark
*
Author to whom correspondence should be addressed.
Diagnostics 2025, 15(9), 1159; https://doi.org/10.3390/diagnostics15091159
Submission received: 2 April 2025 / Revised: 24 April 2025 / Accepted: 30 April 2025 / Published: 2 May 2025
(This article belongs to the Collection Interesting Images)

Abstract

:
A 47-year-old woman presented with fever, fatigue, night sweats and inguinal glandular swelling following a tick bite. Weeks of diagnostic uncertainty followed, and a lymph node biopsy was sent to be investigated for tularemia and pathology. An 18F-FDG PET/CT scan was performed due to a suspicion of malignant lymphoma. The scan revealed high metabolic activity in the left inguinal region, which was compatible with abscesses. The diagnosis of glandular tularemia was established on a positive PCR for Francisella tularensis (F. tularensis) and positive F. tularensis serology. This case highlights the challenges of diagnosing tularemia and illustrates the role of imaging.

Figure 1. A 47-year-old woman, previously healthy, presented in July 2024 with pain in the left groin, fever and general malaise following a tick bite five days earlier. An ultrasound scan was performed, revealing enlarged inguinal lymph nodes. The laboratory testing showed elevated C-reactive protein (CRP) at 22 mg/L (normal range 0–10 mg/L). Four days later, the patient developed night sweats and worsening of the pain, and the CRP was measured to 84 mg/L. Treatment with oral penicillin V (1200 mg three times daily for a total of 10 days) was initiated upon suspicion of Lyme borreliosis (Erythema migrans). Three weeks later, the patient was readmitted due to the progression of symptoms, with growing glandular swelling, new-onset inguinal redness, fatigue and continued night sweats. In the meantime, treatment with dicloxacillin for seven days was attempted, due to a suspicion of erysipelas, without improvement. An ultrasound scan showed increased sizes of reactive lymph nodes, and repeated blood work revealed a lower but still elevated CRP at 28 mg/L. A lymph node biopsy was performed and sent for culture, pathology and PCR for Francisella tularensis (F. tularensis) and Mycobacterium tuberculosis. The patient then initiated empiric treatment with doxycycline. Additional diagnostic work-up included serology (HIV, syphilis, cytomegalovirus, Epstein–Barr virus, toxoplasmosis, tick-borne encephalitis virus, bartonella, quantiferon) and blood cultures. All came out negative. The prolonged course of illness, the presence of B-symptoms, the lack of response to the initial antibiotic treatment, and the diagnostic uncertainty raised concerns of a malignant etiology, prompting an 18F-FDG PET/CT scan. The patient was scanned on a GE Discovery MI 5 ring PET/CT scanner. The scan included a diagnostic CT with contrast enhancement using Omnipaque (350 mg I/mL), with a 110 mL intravenous injection. The PET tracer F-18-FDG 199 MBq was administered by intravenous injection approximately one hour before acquisition. The scan (Figure 1) showed a maximal intensity projection and axial fused 18F-FDG PET/CT with high metabolic activity in the subcutaneous phlegmone/abscess in the left inguinal region (arrow 1), with stranding in the surrounding subcutaneous fat and high metabolic activity in enlarged lymph nodes along the left iliacal vessels, one of which had an internal abscess (arrow 2). The abscess measured 4.3 × 2.4 cm, with an SUVmax of 14.5, and the largest lymph node measured 3.2 × 1.9 cm. The SUVmax of the iliacal lymph nodes was 14.3 (for reference, the liver SUVmax was 4.0). The diagnosis of glandular tularemia was established when the PCR for F. tularensis on the lymph node biopsy that was performed earlier came out positive alongside a positive F. tularensis serology. The 18F-FDG PET/CT and clinical manifestation corroborated this finding. PCR and cultivation for Mycobacterium tuberculosis from the lymph nodes were both negative. The patient continued doxycycline 200 mg daily for a total of four weeks, resulting in clinical improvement and CRP normalization. A follow-up ultrasound scan performed after completed treatment revealed resolution of the abscess and regression of lymphadenopathy [1]. Tularemia is a zoonotic infection caused by the Gram-negative bacteria F. tularensis. The transmission routes of F. tularensis include contact with tissues of infected animals, inhalation of aerosols, consumption of contaminated water or food and arthropod bites, e.g., by ticks [2,3]. An overall increase in cases of tick-borne diseases, including tularemia, has been reported, emphasizing the importance of clinical awareness to ensure timely diagnosis and treatment [4]. The clinical presentation of tularemia varies depending on the route of transmission, virulence and patient’s immune status. The wide spectrum of clinical presentations can complicate the diagnostic process, potentially resulting in treatment delays. Manifestations include ulcero-glandular, glandular, oro-pharyngeal, pneumonic, typhoidal and oculo-glandular tularemia [3,5]. The diagnosis of tularemia is based on serology with the identification of specific F. tularensis antibodies in serum or detection of F. tularensis DNA using PCR in relevant samples [5]. Consequently, 18F-FDG PET/CT is not part of the standard diagnostic work-up. However, given the significant variety of clinical manifestations and the non-specific symptoms seen in tularemia, several differential diagnoses may be relevant, and 18F-FDG PET/CT can be a valuable tool for discriminating between malignant and inflammatory conditions, as reported in this case. To the best of our knowledge, no other data on 18F-FDG-PET/CT findings in glandular tularemia have been reported. However, a few published cases describe 18F-FDG PET/CT scan findings in pneumonic tularemia. Similarly to the presented case, the scans were performed due to suspicion of malignancy, with pneumonic tularemia mimicking lung cancer. Scans revealed a high FDG uptake in lymph nodes and pulmonary lesions that were compatible with pneumonic tularemia; however, they were not specific to the disease. These cases illustrate the diagnostic challenges of tularemia and conclude that pneumonic tularemia is an important differential diagnosis to lung cancer in endemic areas. Furthermore, they demonstrate that exposure history, as well as the presence of infectious symptoms, is crucial in targeting the diagnosis of tularemia [6,7]. The presented case also highlights the diagnostic challenges of tularemia, whose symptoms may mimic malignancy. Our case suggests that 18F-FDG PET/CT can be a useful tool in similar cases to aid the decision to target diagnostic efforts at infectious etiologies. With scan findings, as in the presented case, showing glandular inflammation correlated with a history of tick exposure, clinicians should consider tularemia as a potential diagnosis.
Figure 1. A 47-year-old woman, previously healthy, presented in July 2024 with pain in the left groin, fever and general malaise following a tick bite five days earlier. An ultrasound scan was performed, revealing enlarged inguinal lymph nodes. The laboratory testing showed elevated C-reactive protein (CRP) at 22 mg/L (normal range 0–10 mg/L). Four days later, the patient developed night sweats and worsening of the pain, and the CRP was measured to 84 mg/L. Treatment with oral penicillin V (1200 mg three times daily for a total of 10 days) was initiated upon suspicion of Lyme borreliosis (Erythema migrans). Three weeks later, the patient was readmitted due to the progression of symptoms, with growing glandular swelling, new-onset inguinal redness, fatigue and continued night sweats. In the meantime, treatment with dicloxacillin for seven days was attempted, due to a suspicion of erysipelas, without improvement. An ultrasound scan showed increased sizes of reactive lymph nodes, and repeated blood work revealed a lower but still elevated CRP at 28 mg/L. A lymph node biopsy was performed and sent for culture, pathology and PCR for Francisella tularensis (F. tularensis) and Mycobacterium tuberculosis. The patient then initiated empiric treatment with doxycycline. Additional diagnostic work-up included serology (HIV, syphilis, cytomegalovirus, Epstein–Barr virus, toxoplasmosis, tick-borne encephalitis virus, bartonella, quantiferon) and blood cultures. All came out negative. The prolonged course of illness, the presence of B-symptoms, the lack of response to the initial antibiotic treatment, and the diagnostic uncertainty raised concerns of a malignant etiology, prompting an 18F-FDG PET/CT scan. The patient was scanned on a GE Discovery MI 5 ring PET/CT scanner. The scan included a diagnostic CT with contrast enhancement using Omnipaque (350 mg I/mL), with a 110 mL intravenous injection. The PET tracer F-18-FDG 199 MBq was administered by intravenous injection approximately one hour before acquisition. The scan (Figure 1) showed a maximal intensity projection and axial fused 18F-FDG PET/CT with high metabolic activity in the subcutaneous phlegmone/abscess in the left inguinal region (arrow 1), with stranding in the surrounding subcutaneous fat and high metabolic activity in enlarged lymph nodes along the left iliacal vessels, one of which had an internal abscess (arrow 2). The abscess measured 4.3 × 2.4 cm, with an SUVmax of 14.5, and the largest lymph node measured 3.2 × 1.9 cm. The SUVmax of the iliacal lymph nodes was 14.3 (for reference, the liver SUVmax was 4.0). The diagnosis of glandular tularemia was established when the PCR for F. tularensis on the lymph node biopsy that was performed earlier came out positive alongside a positive F. tularensis serology. The 18F-FDG PET/CT and clinical manifestation corroborated this finding. PCR and cultivation for Mycobacterium tuberculosis from the lymph nodes were both negative. The patient continued doxycycline 200 mg daily for a total of four weeks, resulting in clinical improvement and CRP normalization. A follow-up ultrasound scan performed after completed treatment revealed resolution of the abscess and regression of lymphadenopathy [1]. Tularemia is a zoonotic infection caused by the Gram-negative bacteria F. tularensis. The transmission routes of F. tularensis include contact with tissues of infected animals, inhalation of aerosols, consumption of contaminated water or food and arthropod bites, e.g., by ticks [2,3]. An overall increase in cases of tick-borne diseases, including tularemia, has been reported, emphasizing the importance of clinical awareness to ensure timely diagnosis and treatment [4]. The clinical presentation of tularemia varies depending on the route of transmission, virulence and patient’s immune status. The wide spectrum of clinical presentations can complicate the diagnostic process, potentially resulting in treatment delays. Manifestations include ulcero-glandular, glandular, oro-pharyngeal, pneumonic, typhoidal and oculo-glandular tularemia [3,5]. The diagnosis of tularemia is based on serology with the identification of specific F. tularensis antibodies in serum or detection of F. tularensis DNA using PCR in relevant samples [5]. Consequently, 18F-FDG PET/CT is not part of the standard diagnostic work-up. However, given the significant variety of clinical manifestations and the non-specific symptoms seen in tularemia, several differential diagnoses may be relevant, and 18F-FDG PET/CT can be a valuable tool for discriminating between malignant and inflammatory conditions, as reported in this case. To the best of our knowledge, no other data on 18F-FDG-PET/CT findings in glandular tularemia have been reported. However, a few published cases describe 18F-FDG PET/CT scan findings in pneumonic tularemia. Similarly to the presented case, the scans were performed due to suspicion of malignancy, with pneumonic tularemia mimicking lung cancer. Scans revealed a high FDG uptake in lymph nodes and pulmonary lesions that were compatible with pneumonic tularemia; however, they were not specific to the disease. These cases illustrate the diagnostic challenges of tularemia and conclude that pneumonic tularemia is an important differential diagnosis to lung cancer in endemic areas. Furthermore, they demonstrate that exposure history, as well as the presence of infectious symptoms, is crucial in targeting the diagnosis of tularemia [6,7]. The presented case also highlights the diagnostic challenges of tularemia, whose symptoms may mimic malignancy. Our case suggests that 18F-FDG PET/CT can be a useful tool in similar cases to aid the decision to target diagnostic efforts at infectious etiologies. With scan findings, as in the presented case, showing glandular inflammation correlated with a history of tick exposure, clinicians should consider tularemia as a potential diagnosis.
Diagnostics 15 01159 g001

Author Contributions

F.G. assembled and wrote the manuscript; K.K.R. performed and described the scan; K.T. led the diagnostic work-up of the patient and reviewed the manuscript; A.-M.L. reviewed and edited the manuscript; L.F. supervised F.G. and reviewed and edited the manuscript. All authors have read and agreed to the published version of the manuscript.

Funding

L.F. was supported by a research grant from the Research Fund of Copenhagen University Hospital—Rigshospitalet. A.-M.L. was supported by a research grant from the Lundbeck foundation (R366-2021-127), Research Fund of Copenhagen University Hospital—Rigshospitalet, Independent Research Fund Denmark (10.46540/4285-00139B), and Svend Andersen’s foundation.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Written informed consent has been obtained from the patient to publish this paper.

Data Availability Statement

Not applicable.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Foged, C.; Thorsteinsson, K.; Mens, H.; Helleberg, M.; Lebech, A.M. Tularaemia is often underdiagnosed. Ugeskr Laeger, 2025, in press.
  2. Nelson, C.A.; Winberg, J.; Bostic, T.D.; Davis, K.M.; Fleck-Derderian, S. Systematic Review: Clinical Features, Antimicrobial Treatment, and Outcomes of Human Tularemia, 1993–2023. Clin. Infect. Dis. 2024, 78 (Suppl. S1), S15–S28. [Google Scholar] [CrossRef] [PubMed]
  3. Antonello, R.M.; Giacomelli, A.; Riccardi, N. Tularemia for clinicians: An up-to-date review on epidemiology, diagnosis, prevention and treatment. Eur. J. Intern. Med. 2025, in press. [CrossRef] [PubMed]
  4. Tularaemia: Annual Epidemiological Report for 2019. Available online: https://www.ecdc.europa.eu/en/publications-data/tularaemia-annual-epidemiological-report-2019 (accessed on 12 March 2025).
  5. Maurin, M.; Pondérand, L.; Hennebique, A.; Pelloux, I.; Boisset, S.; Caspar, Y. Tularemia treatment: Experimental and clinical data. Front. Microbiol. 2023, 14, 1348323. [Google Scholar] [CrossRef] [PubMed]
  6. Martinet, P.; Khatchatourian, L.; Saidani, N.; Fangous, M.S.; Goulon, D.; Lesecq, L.; Le Gall, F.; Guerpillon, B.; Corre, R.; Bizien, N.; et al. Hypermetabolic pulmonary lesions on FDG-PET/CT: Tularemia or neoplasia? Infect. Dis. Now 2021, 51, 607–613. [Google Scholar] [CrossRef] [PubMed]
  7. Kravdal, A.; Stubhaug, Ø.O.; Wågø, A.G.; Sætereng, M.S.; Amundsen, D.; Piekuviene, R.; Kristiansen, A. Pulmonary tularaemia: A differential diagnosis to lung cancer. ERJ Open Res. 2020, 6, 00093–2019. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Gustafsson, F.; Rasmussen, K.K.; Thorsteinsson, K.; Lebech, A.-M.; Fjordside, L. 18F-FDG PET/CT Findings in Glandular Tularemia. Diagnostics 2025, 15, 1159. https://doi.org/10.3390/diagnostics15091159

AMA Style

Gustafsson F, Rasmussen KK, Thorsteinsson K, Lebech A-M, Fjordside L. 18F-FDG PET/CT Findings in Glandular Tularemia. Diagnostics. 2025; 15(9):1159. https://doi.org/10.3390/diagnostics15091159

Chicago/Turabian Style

Gustafsson, Freja, Karl Keigo Rasmussen, Kristina Thorsteinsson, Anne-Mette Lebech, and Lasse Fjordside. 2025. "18F-FDG PET/CT Findings in Glandular Tularemia" Diagnostics 15, no. 9: 1159. https://doi.org/10.3390/diagnostics15091159

APA Style

Gustafsson, F., Rasmussen, K. K., Thorsteinsson, K., Lebech, A.-M., & Fjordside, L. (2025). 18F-FDG PET/CT Findings in Glandular Tularemia. Diagnostics, 15(9), 1159. https://doi.org/10.3390/diagnostics15091159

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop